173 related articles for article (PubMed ID: 35215259)
1. Photolytic Controlled Release Formulation of Methotrexate Loaded in Chitosan/TiO
Al-Nemrawi N; Hameedat F; Al-Husein B; Nimrawi S
Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215259
[TBL] [Abstract][Full Text] [Related]
2. A novel formulation of chitosan nanoparticles functionalized with titanium dioxide nanoparticles.
Al-Nemrawi N; Nimrawi S
J Adv Pharm Technol Res; 2021; 12(4):402-407. PubMed ID: 34820317
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of photocatalytic polyurethane and poly(methyl methacrylate) microcapsules for the controlled release of methotrexate.
Al-Nemrawi NK; Marques J; Tavares CJ; Oweis RJ; Al-Fandi MG
Drug Dev Ind Pharm; 2018 Dec; 44(12):2083-2088. PubMed ID: 30112927
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate loaded on magnetite iron nanoparticles coated with chitosan: Biosynthesis, characterization, and impact on human breast cancer MCF-7 cell line.
Ali EMM; Elashkar AA; El-Kassas HY; Salim EI
Int J Biol Macromol; 2018 Dec; 120(Pt A):1170-1180. PubMed ID: 30172815
[TBL] [Abstract][Full Text] [Related]
5. Novel Chitosan Nanoparticles Loaded with Methotrexate for Topical Treatment of Psoriasis.
Al-Nemrawi NK; Khafajah AS; Alzoubi KH
Pharm Nanotechnol; 2023; 11(5):460-474. PubMed ID: 37132113
[TBL] [Abstract][Full Text] [Related]
6. Transdermal Delivery of Methotrexate Loaded in Chitosan Nanoparticles to Treat Rheumatoid Arthritis.
Al-Nemrawi N; Wahsheh Y; Alzoubi KH
Curr Drug Deliv; 2024; 21(3):451-460. PubMed ID: 37132147
[TBL] [Abstract][Full Text] [Related]
7. A novel methotrexate delivery system based on chitosan-methotrexate covalently conjugated nanoparticles.
Wu P; He X; Wang K; Tan W; He C; Zheng M
J Biomed Nanotechnol; 2009 Oct; 5(5):557-64. PubMed ID: 20201432
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
[TBL] [Abstract][Full Text] [Related]
9. Validation of a Janus role of methotrexate-based PEGylated chitosan nanoparticles in vitro.
Luo F; Li Y; Jia M; Cui F; Wu H; Yu F; Lin J; Yang X; Hou Z; Zhang Q
Nanoscale Res Lett; 2014; 9(1):363. PubMed ID: 25114653
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Methotrexate Loaded Chitosan Nanoparticles and in vitro Evaluation of the Potential in Treatment of Prostate Cancer.
Nur SG; Buket O; Sezgi K; Cagdas A; Cansu A; Guliz A; Habibe Y; Cigir BA; Yavuz D; Senay HS
Anticancer Agents Med Chem; 2016; 16(8):1038-1042. PubMed ID: 26721835
[TBL] [Abstract][Full Text] [Related]
11. Lactobionic acid-modified thymine-chitosan nanoparticles as potential carriers for methotrexate delivery.
Wang J; Zhang Z; Ai Y; Liu F; Chen MM; Liu D
Carbohydr Res; 2021 Mar; 501():108275. PubMed ID: 33657498
[TBL] [Abstract][Full Text] [Related]
12. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
[TBL] [Abstract][Full Text] [Related]
13. Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade.
Hamed A; Ghareeb D; Mohamed TM; Hamed M; Nofal MS; Gaber M
BMC Complement Med Ther; 2023 Oct; 23(1):384. PubMed ID: 37891562
[TBL] [Abstract][Full Text] [Related]
14. Surface functionalization of methotrexate-loaded chitosan nanoparticles with hyaluronic acid/human serum albumin: Comparative characterization and in vitro cytotoxicity.
Hashad RA; Ishak RA; Geneidi AS; Mansour S
Int J Pharm; 2017 Apr; 522(1-2):128-136. PubMed ID: 28279742
[TBL] [Abstract][Full Text] [Related]
15. Development of chitosan and polylactic acid based methotrexate intravitreal micro-implants to treat primary intraocular lymphoma: an in vitro study.
Manna S; Augsburger JJ; Correa ZM; Landero JA; Banerjee RK
J Biomech Eng; 2014 Feb; 136(2):021018. PubMed ID: 24317155
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and formulation of methotrexate (MTX) conjugated LaF3:Tb(3+)/chitosan nanoparticles for targeted drug delivery applications.
Mangaiyarkarasi R; Chinnathambi S; Aruna P; Ganesan S
Biomed Pharmacother; 2015 Feb; 69():170-8. PubMed ID: 25661354
[TBL] [Abstract][Full Text] [Related]
17. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate-loaded chitosan- and glycol chitosan-based nanoparticles: a promising strategy for the administration of the anticancer drug to brain tumors.
Trapani A; Denora N; Iacobellis G; Sitterberg J; Bakowsky U; Kissel T
AAPS PharmSciTech; 2011 Dec; 12(4):1302-11. PubMed ID: 21948322
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate-conjugated chitosan-grafted pH- and thermo-responsive magnetic nanoparticles for targeted therapy of ovarian cancer.
Fathi M; Barar J; Erfan-Niya H; Omidi Y
Int J Biol Macromol; 2020 Jul; 154():1175-1184. PubMed ID: 31730949
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line.
Nosrati H; Adinehvand R; Manjili HK; Rostamizadeh K; Danafar H
Pharm Dev Technol; 2019 Jan; 24(1):89-98. PubMed ID: 29307260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
